daunorubicin has been researched along with pyrrolopyrimidine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schmitt, SM; Stefan, K; Wiese, M | 1 |
1 other study(ies) available for daunorubicin and pyrrolopyrimidine
Article | Year |
---|---|
Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1).
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Daunorubicin; Dogs; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Fluorescent Dyes; Gene Expression; Humans; Kinetics; Madin Darby Canine Kidney Cells; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Purines; Pyrimidines; Pyrroles; Structure-Activity Relationship | 2017 |